title: Plasma pharmacokinetics of alfaxalone in both premedicated and unpremedicated Greyhound dogs after single, intravenous administration of Alfaxan at a clinical dose.
authors.affiliation: Jurox Pty Ltd, 85 Gardiner Road, Rutherford, NSW 2320, Australia. kirby.pasloske@jurox.com.au
authors.forename: K
authors.initials: K
authors.lastname: Pasloske
authors.forename: B
authors.initials: B
authors.lastname: Sauer
authors.forename: N
authors.initials: N
authors.lastname: Perkins
authors.forename: T
authors.initials: T
authors.lastname: Whittem
mesh_terms: D000075:Acepromazine / Q000494:pharmacology; D000701:Analgesics, Opioid / Q000494:pharmacology; D000758:Anesthesia / Q000662:veterinary; D018686:Anesthetics, Intravenous / Q000097:blood / Q000493:pharmacokinetics*; D000818:Animals; D004285:Dogs / Q000378:metabolism; D005260:Female; D007275:Injections, Intravenous; D008297:Male; D009020:Morphine / Q000494:pharmacology; D011229:Preanesthetic Medication / Q000662:veterinary; D011277:Pregnanediones / Q000097:blood / Q000493:pharmacokinetics*
chemical_list: D000701:Analgesics, Opioid; D018686:Anesthetics, Intravenous; D011277:Pregnanediones; D000075:Acepromazine; D009020:Morphine; C006477:alphaxalone